Skip to main content
. 2017 Mar 31;28(7):1560–1568. doi: 10.1093/annonc/mdx152

Table 1.

Baseline patient characteristics

Factors MA.5 MA.12 MA.14 MA.21 MA.27 HERA
Total N 710 672 665 2083 7571 3028
Age < 50 84% 82% 3% 61% 3% 51%
Menopausal status: Pre/uncertain 100% 100% 0% 68% 0% 54%
Race White n/a n/a 97% 89% 95% 83%
ECOG performance 0 81% 65% 78% 84% 82% 91%
Node positive 100% 75% 47% 72% 28% 64%
T1/in situ 37% 43% 58% 35% 72% 35%
Hormone receptor positive 68% 75% 91% 61% 100% 51%
Chemotherapy 100% 100% 31% 100% 31% 100%
Anthracyclines 49% 55% 25% 100% 28% 93%